Sign inGet started

ABELES JOHN H

Insider CIK 902418 · CBMX Director · NTRP 10% owner · MDIT Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
MDIT Medite Cancer Diagnostics, P Buy2018-10-112018-10-23266,667$0.08 $21.3K1,566,852SEC↗
MDIT Medite Cancer Diagnostics, J Other2018-08-132018-10-2340,000— $01,300,185SEC↗
MDIT Medite Cancer Diagnostics, P Buy2018-07-032018-07-10400,000$0.08 $32.0K2,608,381SEC↗
NTRP Neurotrope, Inc. P Buy deriv2015-11-132015-11-17208,334— $0208,334SEC↗
NTRP Neurotrope, Inc. P Buy deriv2015-11-132015-11-172,083— $0208,334SEC↗
NTRP Neurotrope, Inc. A Award deriv2015-11-132015-11-17166,667— $0166,667SEC↗
NTRP Neurotrope, Inc. A Award deriv2015-11-132015-11-17166,667— $0166,667SEC↗
NTRP Neurotrope, Inc. A Award deriv2015-11-132015-11-17166,667— $0166,667SEC↗
NTRP Neurotrope, Inc. P Buy deriv2015-11-132015-11-17208,334— $0208,334SEC↗
NTRP Neurotrope, Inc. P Buy deriv2015-11-132015-11-17208,334— $0208,334SEC↗
NTRP Neurotrope, Inc. P Buy deriv2015-11-132015-11-17208,334— $0208,334SEC↗
NTRP Neurotrope, Inc. P Buy deriv2015-11-132015-11-17208,334— $0208,334SEC↗
NTRP Neurotrope, Inc. A Award deriv2015-11-132015-11-171,667— $0166,667SEC↗
NTRP Neurotrope, Inc. A Award deriv2015-11-132015-11-17166,667— $0166,667SEC↗
NTRP Neurotrope, Inc. A Award deriv2015-11-132015-11-17166,667— $0166,667SEC↗
CBMX CombiMatrix Corp A Award deriv2012-01-032012-01-0520,000— $020,000SEC↗